Host: Larry Kaskel, MD

Guest: James Ehrlich, MD

The means for assessing cardiovascular risk include several new high technology developments. Dr. James Ehrlich, MD, a veteran in the development of advanced coronary risk assessment centers, educates us on the role of electron beam computed tomography (EBCT), endothelial function testing, and aspirin resistance testing in preventative cardiology. Dr. Ehrlich also examines the research concerning new biomarkers of vascular disease, such C-reactive protein and urine thrombaxane B2. Host Dr. Kaskel reviews with Dr Ehrlich the protocols for using these high tech devices prior to or in conjunction with ordering advanced imaging tests.

Brought to you by: